Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferinject in chronic heart failure with iron deficiency
NCT00520780Phase 3Completed
- Sponsor
- CSL Vifor
- Start
- Apr 2007
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by CSL Vifor. Started Apr 2007; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT00520780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00520780.